Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Recombinant and plasma-derived factor VIII products induce distinct splenic cytokine microenvironments in hemophilia A mice

Mohammad Qadura, Braden Waters, Erin Burnett, Rouzbeh Chegeni, Scott Bradshaw, Christine Hough, Maha Othman, David Lillicrap

Blood (2009) 114 (4): 871–880.

https://doi.org/10.1182/blood-2008-09-174649

Published: 2009

Includes: Supplemental data

Journal Articles

Anti-CD3 prevents factor VIII inhibitor development in hemophilia A mice by a regulatory CD4 + CD25 + -dependent mechanism and by shifting cytokine production to favor a Th1 response

Braden Waters, Mohammad Qadura, Erin Burnett, Rouzbeh Chegeni, Andrea Labelle, Patrick Thompson, Christine Hough, David Lillicrap

Blood (2009) 113 (1): 193–203.

https://doi.org/10.1182/blood-2008-04-151597

Published: 2009

Includes: Supplemental data

Journal Articles

Anti-CD3 Therapy Expands the CD4 + CD25 + Compartment in Hemophilia a Mice Inducing Tregs That Potently Prevent Factor VIII Inhibitor Formation

Braden Waters, B.Sc. H, Mohammad Qadura, B.Sc.H, Erin Burnett, Rouzbeh Chegeni, PhD, Andrea Labelle, Patrick Thompson, David Lillicrap, MD

Blood (2008) 112 (11): 241.

https://doi.org/10.1182/blood.V112.11.241.241

Published: 2008

Journal Articles

Investigating the Mechanisms Underlying FVIII Antibody Production in Hemophilic Mice Following Recombinant and Plasma-Derived FVIII Infusion

Mohammad Qadura, BSc, Braden Waters, BSc, Erin Burnett, BSc, Rouzbeh Chegeni, BSc, MSc, PhD, Maha Othman, PhD, MD, David Lillicrap, MD

Blood (2008) 112 (11): 237.

https://doi.org/10.1182/blood.V112.11.237.237

Published: 2008

Journal Articles

Reduction in Factor VIII Inhibitors Mediated through Tolerogenic Antigen Presentation by immature Dendritic Cells.

Mohammad Qadura, BSc, Andrea Labelle, Kirsten Walker, Kathleen Pratt, PhD, Maha Othman, MD, PhD, Christine Hough, PhD, David Lillicrap, MD

Blood (2006) 108 (11): 762.

https://doi.org/10.1182/blood.V108.11.762.762

Published: 2006

NARROW

Recombinant and plasma-derived factor VIII products induce distinct splenic cytokine microenvironments in hemophilia A mice

Anti-CD3 prevents factor VIII inhibitor development in hemophilia A mice by a regulatory CD4 + CD25 + -dependent mechanism and by shifting cytokine production to favor a Th1 response

Anti-CD3 Therapy Expands the CD4 + CD25 + Compartment in Hemophilia a Mice Inducing Tregs That Potently Prevent Factor VIII Inhibitor Formation

Investigating the Mechanisms Underlying FVIII Antibody Production in Hemophilic Mice Following Recombinant and Plasma-Derived FVIII Infusion

Reduction in Factor VIII Inhibitors Mediated through Tolerogenic Antigen Presentation by immature Dendritic Cells.

Email alerts

ASH Publications

American Society of Hematology

Recombinant and plasma-derived factor VIII products induce distinct splenic cytokine microenvironments in hemophilia A mice

Anti-CD3 prevents factor VIII inhibitor development in hemophilia A mice by a regulatory CD4 + CD25 + -dependent mechanism and by shifting cytokine production to favor a Th1 response

Anti-CD3 Therapy Expands the CD4 + CD25 + Compartment in Hemophilia a Mice Inducing Tregs That Potently Prevent Factor VIII Inhibitor Formation

Investigating the Mechanisms Underlying FVIII Antibody Production in Hemophilic Mice Following Recombinant and Plasma-Derived FVIII Infusion

Reduction in Factor VIII Inhibitors Mediated through Tolerogenic Antigen Presentation by immature Dendritic Cells.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only